Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
1.260
-0.330 (-20.75%)
At close: Nov 28, 2025, 1:00 PM EST
1.280
+0.020 (1.59%)
After-hours: Nov 28, 2025, 4:59 PM EST
Zynex Revenue
Zynex had revenue of $13.36M in the quarter ending September 30, 2025, a decrease of -73.26%. This brings the company's revenue in the last twelve months to $108.20M, down -44.13% year-over-year. In the year 2024, Zynex had annual revenue of $192.35M with 4.36% growth.
Revenue (ttm)
$108.20M
Revenue Growth
-44.13%
P/S Ratio
0.36
Revenue / Employee
$108,202
Employees
1,000
Market Cap
38.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 192.35M | 8.03M | 4.36% |
| Dec 31, 2023 | 184.32M | 26.16M | 16.54% |
| Dec 31, 2022 | 158.17M | 27.87M | 21.39% |
| Dec 31, 2021 | 130.30M | 50.18M | 62.63% |
| Dec 31, 2020 | 80.12M | 34.65M | 76.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ZYXI News
- 11 days ago - Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 12 days ago - Zynex Reports Third Quarter 2025 Financial Results - PRNewsWire
- 15 days ago - Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee - PRNewsWire
- 15 days ago - Zynex Sets Third Quarter 2025 Earnings Call - PRNewsWire
- 6 weeks ago - Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair - PRNewsWire
- 3 months ago - Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles - PRNewsWire
- 3 months ago - Zynex, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 4 months ago - Zynex Q2 Revenue Drops 55% - The Motley Fool